Trial Profile
A Preliminary Study of Prophylactic Fentanyl Pectin Nasal Spray (FPNS) for Exercise-Induced Breakthrough Dyspnea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2020
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Dyspnoea
- Focus Therapeutic Use
- 10 Jan 2020 Status changed from active, no longer recruiting to completed.
- 10 May 2019 Planned End Date changed from 1 Jun 2019 to 1 Jun 2020.
- 27 Jun 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2019.